2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Cifra de Afaceri - Ron | 614.769 | 568.705 | 530.082 | 559.573 | 624.612 | 658.410 | 761.629 | 789.216 | 884.281 | 969.788 |
Venituri Totale - Ron | 621.369 | 594.794 | 543.474 | 566.737 | 631.673 | 668.187 | 774.596 | 795.268 | 907.772 | 1.008.436 |
Cheltuieli Totale - Ron | 597.086 | 582.286 | 541.078 | 540.591 | 593.410 | 645.293 | 685.120 | 715.302 | 798.647 | 880.465 |
Profit/Pierdere Brut - Ron | 24.283 | 12.508 | 2.396 | 26.146 | 38.263 | 22.894 | 89.476 | 79.966 | 109.125 | 127.971 |
Profit/Pierdere Net - Ron | 20.398 | 10.507 | 2.013 | 20.347 | 31.946 | 16.213 | 81.931 | 72.172 | 100.229 | 118.121 |
Salariati | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Verifica rapoartele financiare pentru firma - Eritrofarm S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Active Imobilizate | 69.426 | 69.426 | 69.426 | 69.426 | 69.426 | 47.616 | 47.616 | 47.616 | 47.616 | 47.616 |
Active Circulante | 316.291 | 246.902 | 198.495 | 212.934 | 255.522 | 259.505 | 298.731 | 323.313 | 303.730 | 384.656 |
Stocuri | 196.585 | 134.340 | 129.952 | 117.704 | 137.786 | 140.418 | 155.441 | 143.921 | 148.798 | 170.733 |
Creante | 72.417 | 46.678 | 21.835 | 61.503 | 82.452 | 70.688 | 103.257 | 102.436 | 103.109 | 105.805 |
Casa si conturi | 47.289 | 65.884 | 46.708 | 33.727 | 35.284 | 48.399 | 40.033 | 76.956 | 51.823 | 108.118 |
Capitaluri Proprii | 66.357 | 56.466 | 58.479 | 78.825 | 110.771 | 62.172 | 144.104 | 118.131 | 146.188 | 164.080 |
Capital Social | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 |
Datorii | 319.360 | 259.862 | 209.442 | 203.535 | 214.177 | 244.949 | 202.243 | 252.798 | 205.158 | 268.192 |
Venituri in Avans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Curs valutar - RON | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
CAEN Principal | "4773 - 4773" | |||||||||
CAEN An Financiar |
4773
|
Abonamente Rapoarte Financiare
Poti verifica nelimitat situatia financiara a firmelor raportata la industria din care face parte, limitele de creditare si riscul de insolventa si de oprire al conturilor.
Comentarii - Eritrofarm S.r.l.